<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 150 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page149.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=150">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 150 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 150</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=150"><img src="../thumb/150.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.9                                                 2020-04 / 119
       MICARDIS, Ing.Pharm. [P/S]    Dosage: Recomm.dos: 40 mg once dly. Incr.to max. of 80 mg once   lactat.not est., mod.to sev.hepat.funct. impairm. &/cholestas., safety
       Telmisartan                   dly.as indicat.by respons.or use altern.in combinat.with low dos. hy-  & effic.in childr.not est., Addison’s dis., anur., gout, galact.intol., Lapp
       Indications: Mild to mod.hypertens.alone/ combin. with hydrochlo-  drochlorothiaz. (12,5 mg). Max.anti-hypertens. eff.is gen.attain.4-8   lactase defic., gluc.-galact.malabsorpt.
       rothiazide, cardiovasc. morbidit.& mortalit.reduct.in pts.55 yrs or old.  wks.aft.start of treatm. Do not exceed 40 mg once dly.in pts.with   Side-effects: Nasopharyngit., bronchit., dyslipidaem., dizzin., head-
       at high risk of CV dis.       mild to mod. hepat. impairm.  ache, tachycard., resp.infect., sinusit., cough, GI disturbs., abdom. /
       (S3) TABS, 33/7.1.3/0020, 0021.  Contra-indications: Angioed.hist.link.to prev. ACE inhibit./angio-  back pain, flu-like sympt., UTI, inflic.inj., fatig., bld.dyscras., angioed.,
       860387-003: 40 mg, 28, R325,93  tensin recept.block., heredit./ idiopath. angioed., hypertroph.obstruct.   hyperkalaem., hyponatraem., vertigo, hypotens., incr.liv.enzym., ab-
       860395-006: 80 mg, 28, R325,93  cardiomyopathy, sev.ren.impairm., bil.ren.artery stenos., ren.artery   norm.hepat.funct./hepatit., skin reacts.incl.tox. epiderm.necrolys./
                                                          +
       Dosage: Adults: Essential hypertens: Recomm. dos: 40 mg once   stenos. sngl.funct.kidn., aort. stenos., concom. Li/K spar.diuret., por-  cutan.lupus erythrematos. reactivat., photosens., arthralg., myalg.,
       dly. Incr.to max. of 80 mg once dly.as indicat.by respons.or use altern.  phyr., pregn., lactat., sev.hepat.impairm., bil.obstruct. disords., safety   imp.ren. funct.incl.ren. fail., anaphylact.reacts., hyperglycaem., hy-
       in combinat. with low dos hydrochlorothiaz.(12,5 mg). Max. anti-  & effic.in childr.und.18 yrs.not est.  peruricaem., electrol.imbal., psych. disords., CNS effs., vertigo, par-
       hypertens. eff.gen.attain.4-8 wks.aft.start of treatm. Mild to mod.  Side effects: UTI, URTI, sepsis incl.fatal outcome, anaem., eosino-  aesthes., blurr./yellow vis., card.dysrhythm., post.hypotens., necro-
       hepat.impairm: Do not exceed 40 mg once dly.  phil., thrombocytopen., neutropen., hypersens. incl.anaphylact.react.,   tis.angitis, resp.distress, pancreatit., jaund., musc.spasm, glycosur.,
       Cardiovasc.morbidit. & mortalit. reduct: Recomm. dos: 80 mg   angio-oed.also with fatal outcome, hyperkalaem., hypoglycaem., de-  interstit.nephrit., weakn., fev., cholester./triglycer.incr.
       once dly. Treatm.benef. evid.aft.6 mnths.of contin.ther.   press., insomn., anx., syncope, somnol., headache, dizzin., fatig., vis.  Special precautions: No re-challenge in case of angioed.hist.relat.
       Contraindications: Angioed.hist.link.to prev. ACE inhibit./angio-  disturbs., vertigo, bradycard., tachycard., hypotens., orthostat. hypo-  to prev.ACE inhibits./ARB ther., discont. ther.when pregn.plann./con-
       tens.recept.block., heredit./idiopath. angioed., hypertroph.obstruct.  tens., dyspn., cough, interstit.lung dis., GI disturbs., abnorm.hepat.  firm., treatm. to be stop.& switch.to a diff.class meds.when pregn.con-
       cardiomyopathy, bil.ren.artery stenos., ren.artery stenos.in sngl.   funct.occurr.main.in Japanese pts., prurit., hyperhidros., rash, eczema,   firm.dur.ther., adeq.contracept.in women of childbear.potent., excret.
       funct.kidn., sev.ren./hepat.impairm., aort.stenos., concom. K spar.  erythema, urticar., drug erupt., tox.skin erupt., back-/tendon-/chest   in breast milk, concom. warfar., monit.ser. K with concom.digoxin/
                                 +
                                                                                     +
       diuret./Li-ther., porphyr., safety in pregn.& lactat.not est., bil.ob-  pain, musc.spasms, arthralg., myalg., extremity pain, ac.ren.fail, ren.  anti-dysrhythm., monit.ser.Ca lev.with concom.Ca supplem./Vit.D,
       struct.disords., fruct. intol., concom.aliskiren-contain.prod., concom.   impairm., asthen., flu-like illn., incr.bld.creatinine/-creatine phospho-  poss.dos.adjustm.of anti-diab. meds., Li toxic., monit.K / creatin.& uric
                                                                                        +
       fluoroquinolones in mod.-sev.ren.impairm.& elderly, safety & effic.   kin., Hb decr., decr.uric acid, hepat.enzym.incr.,  acid in sev.imp.ren.funct., no exper.in rec.ren.transpl., correct vol./Na
       in childr.und.18 yrs.not est.  Special precautions: Treatm.to be stop.& chang. if pregn.occurs/  deplet.bef.init.ther., bld.urea & ser. creatin. incr.in bil.ren.art.stenos.&
                                                                                        +
                                                                                  +-
       Side effects: UTI, URTI, anaem.thrombocytopen., hypersens. incl.  plan., monit.plasma digox.& Li lev. with concom.ther., adeq.hydrat.&   stenos.in pres. of sngl.kidn., concom.K spar.diuret./K supplem. /salt
       anaphylact.react., hyperkalaem., depress., insomn., anx., syncope,   monit.ren. funct. at begin.of combin.treatm.with concom. NSAID’s,   substit./meds.that incr.or may incr.ser.K  lev., per. monit.of ser.K  in HF,
                                                                                            +
                                                                                  +
       faint., vis. disturbs., vertigo, bradycard., tachycard., hypotens., or-  adeq.contracept.in women of childbear. potent., embroyon.toxic./  surg./anaesthes., concom. meds.that affect renin-angiotens.-aldos-
       thostat.hypotens., cough, dyspn., GI disturbs., dyspeps., dry mouth,   foet.& neonat.morbid.& mortal., incr.sepsis report., incr.sev.hypo-  terone syst., excess.BP reduct.in ischaem. cardiopathy/cerebrovasc.
       abnorm.hepat. funct., liv.disords., incr.sweat., prurit., rash, eczema,   tens.& ren. insuffic.risk with bil.ren.artery stenos./ren. artery stenos.  dis.may result in MI/ stroke.
       erythema, angio-oed., drug erupt., tox.skin erupt., back/chest pain, ar-  sngl.funct.kidn., monit.ser.K & creatinine of risk pts., no exper.in ren.  Drug interactions: Prolong.INR & bleed. complicat. with concom.
       thralg., myalg., leg cramps/ leg pain, ac.ren.fail, ren.impairm., weakn.,   transplant., vol./Na deplet. to be correct.bef.init.ther., when vasc.  warfar., antihypertens. eff.enhanc. by other antihypertens., hypoka-
       flu-like sympts., incr.bld.creatinine/-uric acid/-creatine phosphokin.,   tone & ren.funct.depend.predomin.on renin angiotensin-aldosterone   laem eff.incr.by concom.meds.assoc.with K loss/ hypokalaem.,
                                                                                      +
       Hb decr., hepat.enzym.incr., sepsis incl.fatal outcome, eosinophil.,   syst.activ.concom.meds. affect.that syst., not recomm.in prim. aldos-  potent.cardiotox.effs.of digoxin & anti-dysrhythm.in diuret.induc.
       urticar., tendinit. like sympts., hypoglycaem.in diab.pts.  teronism, concom concom.Kspar.diuret./Ksupplem. or salt substit.  hypokalaem.&-magnesaem., incr.Li ser.conc.& toxic., natriuret./ an-


       Warnings and special precautions: No re-challenge aft.angioed.  contain.K/meds poss. incr. ser.K may lead to incr.ser.K not recomm.,   tihypertens./diuret.eff.weak.by NSAID’s, colestipol/cholestryamine
       react., treatm.to be stop.& chang. if pregn.occurs/plan., monit.plasma   mild to mod.hepat. impairm., baseline GI dis.as GI bleed. report., less   decr.absorpt., non-depolaris. skelet.musc.relax.eff.potent., poss.
       digox.& Li lev.with concom.ther., adeq.hydrat.& monit. ren.funct.at   eff.low.BP in black people, excess.BP reduct.in ischaem.cardiopathy/  incr.ser.Ca lev., enhanc.hyperglycaem.eff.of ß-block.& diazoxide,
       begin.of combin.treatm.with concom. NSAID’s, adeq.contracept.in   ischaem.card.vasc. dis.may result in MI/stroke.  anticholinerg.agents incr. bioavailab., incr.risk of advers.effs.caus.by
       fertile women, human embryon./ fetotox./neonat.toxic.report., mild   Drug interactions: Incr.eff.of other anti-hypertens., incr.digox.plas-  amantadine, reduc.ren.excret.of cytotox.meds.& potent.myelosup-
       to mod.hepat.impairm., biliary obstruct.disords., when vasc.tone &   ma conc., incr.ser.Li conc.& toxic, ac. ren.insuffic.potent.with concom.   press. effs., steroids./ACTH incr. hypokalaem.risk., concom.alcoh./
       ren.funct.depend.predomin.on renin angiotensin-aldosterone syst.ac-  NSAID’s in dehydrat. pts., reduc.antihypertens. eff.with NSAID’s.  barbits./ anaesthet. poss.aggrav.postur.hypotens., gluc.tol. imp.,
       tiv., dual block.of RAAS with ARB’s/ACE inhibit./aliskiren assoc. with   decr.arter.respons.to press.amines, incr.risk of ren.insuffic.with high
       high.freq.hypotens./hyperkalaem.& decr. ren.funct.(incl.ren.fail), incr.  MYLACAND, Mylan [P/S]  dos.iodinat.contrast media.
       sev.hypotens.& ren. insuffic.risk with bil.ren.artery stenos./ren. artery   Candesartan cilexetil
       stenos.sngl.funct.kidn., monit.ser.K & creatinine of risk pts., no exper.in   Indications: Mild to mod.hypertens.alone/ concom. with other anti-  NETRASOL CO, Specpharm
       ren.transplant., vol./Na deplet.to be correct.bef.init.ther., assess ren.  hypertens., reduc.mortality & hospitalisat.due to HF & improv.sympts.  Losartan potassium 50 (100)mg, hydrochlorothiazide 12,5 (25)mg.
       funct.bef.init.treatm.& monit.dur.treatm.with fluoroquinolones/ACE   in L ventr. systol.dysfunct (LVEF &lt;40%)  Indications: Hypertens.in pts.est.on identic.dos. of these indiv.
       inhibit./angiotens.recept. block.whether used separat./concom., not   (S3) TABS, 45/7.1.3/0301, 0302  agents.
       recomm.in prim.aldosteronism, aort./mitral stenos., obstruct.hyper-  719209-001: 8 mg, 30, R145,25  (S3) TABS. 41/7.1.3/1000, 1001
       troph.cardiomyopathy, concom.Kspar.diuret./Ksupplem.or salt sub-  719210-001: 16 mg, 30, R145,25  715848-001: 50(12,5) mg, 30, R89,33


       stit. contain.K/meds poss.incr.ser.K may lead to incr. ser.K., less eff.  Dosage: Hypertens: Recomm.init.dos.: 8 mg once dly. Usual maint:   715849-001: 100(25)mg, 30, R95,71
       low.BP in black people, ischaem. cardiopathy/ischaem.card.vasc.dis.,   8-16 mg once dly. Poss.addit. benef. by incr.dos.to 32 mg once dly.   Dosage: Usual start.& maint.dos: 1x 50/12,5 mg tab. dly. May be
       monit.BP & adjust. meds.that lower BP if appropr.when init. ther.for   Max. antihypertens. eff.attain.within 4 wks of treatm. May be used   incr.to 1x 100/25 mg tab or 2x 50/12,5 mg tabs.once dly.if respons.
       CV morbid.& mortal.prevent.   as monother./combinat.with other antihypertens.  not adeq. Max. dos: 1x 100/25 mg tab. or 2x 50/12,5 mg tabs. dly.
       Interactions: Li conc.& toxic., incr.eff.of other anti-hypertens., incr.  Heart fail: Recomm.init.dos: 4 mg once dly. Up titrat.to target dos.  Max.therapeut.eff.attain.within 3 wks.of init.ther.
       digox.plasma conc., incr.in ramipril & ramiprilat AUC & C max,  ac.ren.  of 32 mg once dly.or high.tol. dos. is done by doubl.dos.at interv.of   Contraindications: Prev.angioed.relat.to ACE/ ARB ther., heredit./
       insuff. potent. with concom.NSAID’s in dehydrat.pts., reduc. antihy-  at least 2 wks. May be admin. in combinat.with other HF treatm.  idiopath.angioed., hypertroph. obstruct. cardiomyopathy, mod.to sev.
       pertens.eff.with NSAID’s, incr. adverse eff.with concom.ACE inhib-  Contra-indications: Angioed.hist. relat.to prev. ther.with ACE   ren.funct. impairm., not recomm.in hepat.funct.impairm., vol-deplet.
       its./ARB’s & aliskiren, ac.kidn.injury with concom. fluoroquinolones.  inhibits./angiotens.recept.blocks., heredit./ idiopath.angioed., hy-  pts., bilat.ren.artery stenos., ren.artery stenos. with sngl.kidn., aort.
                                     pertroph.obstruct. cardiomyopathy, sev.ren.funct.impairm., bilat.  stenos., concom.K+ spar. diuret./Li ther., porphyr., Addison’s dis.,
       MIGROBEN, Novartis [P/S]      ren. art. stenos./ stenos.in pres.of sngl.kidn., aort. stenos., concom.  anuria, sulphonam.hypersens., safety in pregn.& lactat. not est.,
       Valsartan.                    K  spar.diurets., porphyr., Li-ther., safety in pregn.& lactat.not est.,   safety & effic.in childr.not est., galact. intol.hist., Lapp lact.defic.,
                                     +
       Indications: Mild to mod.hypertens.  safety & effic. in childr. not est., galact.intol., Lapp lactase defic/   gluc.-galact. malabsorpt.
       (S3) TABS. 43/7.1.3/0032, 0033  gluc.-galact. malabsorpt.  Side effects: Foet./neonat.jaund., dizzin., orthostat. hypotens., head-
       715568-001: 80 mg, 28, R123,61  Side-effects: Resp.infects., bld.dyscras., angioed., hyponatraem.,   ache, asthen./fatig., electrol.imbal., URTI., bld.disords., cholecystit.,
       715569-001: 160 mg, 28, R123,61  dizzin., headache, vertigo, hypotens.somet.sev., naus., liv.enzyme   pancreatit., oed., palpitat., angioed., insomn., migraine, tachycard.,
       Dosage: Recomm.dos: 80 mg or 160 mg once dly. Substant. eff.  incr., abnorm. hepat.funct., hepatit., skin reacts., back pain, arthralg.,   palpitat., vasculit., cough, nas.congest., pharyngit., sinus disords., GI
       pres.within 2 wks.& max.eff.aft. 4 wks. May be incr.to 320 mg dly.  myalg., ren.impairm.incl.ren.fail., hyperkalaem.  disturbs., taste disturbs., hepatit., hepatotox., cholestas., skin reacts.,
       or add diuret.in pts.not adeq.control. May be admin.with other anti-  Special precautions: No re-challenge in case of angioed. hist.relat.  atypic.cutan.lymph. infiltrates, psorias., musc.cramps/spasm, back/
       hypertens.agents.             to prev.ACE inhibits./ ARB ther., monit.ser. K  & creatin.lev in sev.imp.  leg/chest pain, myalg., arthralg., rhabdomyolys., imp.ren./hepat.
                                                       +
       Contraindications: Pregn., lactat., angioed.relat. to prev.ACE inhibit/  ren.funct./ dur.dos. titrat., monit.ser.Li-lev., stop ther.& switch to diff.   funct., asthen., fatig., hyperkalaem., hyponatraem., sialadenit., ver-
       ARB ther., Li ther., safety & effic. in childr.und.18 yrs.not est., safety   antihypertens. if a woman becom.pregn., adeq.contracept. in women   tigo, paraesthes., xanthopsia, photosens., vasculit., fev., resp. dis-
       in porphyr. not est., heredit./idiopath.angioed., hypertroph. obstruct.  of childbear.potent., excret.in breast milk, discont.ther.if pregn. plann./  tress, hypersens./anaphylact.reacts.with /without allerg./bronch.
       cardiomyopathy, mod.to sev. ren. impairm., bil.ren.artery stenos., ren.  confirm., concom.warfarin, no exper.in sev. hepat.funct.impairm.&/  asthma hist., electrol. imbal., glycosur., hyperglycaem., hyperuricaem.,
                             +
       artery stenos. with sngl.kidn., aort.stenos., concom.K  spar. diuret.  cholestas., antihypertens. eff.less in black pts., correct intravasc.vol.  ren. fail., interstit.nephrit., restlessn., blurr.vis., mark. hypercalcaem.
       Side effects: Hypotens., vir.infects., URTI, pharyngit., sinusit., rhinit.,   deplet. bef. init.ther., pts.over 70 yrs./diab./concom.other meds. in   Special precautions: Poss.tox.Li bld.conc.with concom. use, cor-
       neutropen., thrombocytopen., hypersens.incl.ser.sickn., hyperkalaem.,   treat. HF pts., bil./sngl.ren.art.stenos., no exper.in recent kidn.trans-  rect Na/vol.deplet./electrol. imbal. bef.init.ther., diab.mellit., hyper-
       insomn., decr.libido, syncope, dizzin., headache, vertigo, card.fail.,   pl., per.ser.K lev.monit.in HF esp. with concom.ACE inhibits./K  spar.  glycaem., dos. adjustm.of antidiabet.agents incl.insulin poss., al-
                                          +
                                                              +
       vasculit., cough, GI disturbs., angioneurot.oed., rash, prurit., purpura,   diurets., anaesthes./ surg., excess.BP decr.in ischaem. cardiopathy/   lerg./bronch.asthma, gout/hyperuricaem. poss. exacerb./precipitat.,
       psorias., back pain, arthralg., myalg., ren. impairm., ac.ren.fail., fatig.,   CV dis.poss.result in MI/stroke.  admin.1 hr bef. cholestyramine /colestipol intake ,SLE poss.activ. /
       asthen., oed., elev.LFT.      Drug interactions: Incr.ser.Li conc., antihypertens. eff. enhanc.  exacerb., adeq.contracept.for women of childbear. age, foet.toxic./
       Special precautions: Na & vol.deplet.theref. correct. bef.init.  by other antihypertens., incr.INH/bleed.with warfarin, incr.ser.K   +  teratogenicity shown in experim. animals, cross.placenta, discont.
                                        +
       ther., incr.mortalit.in HF pts. receiv. ACE inhibit./beta-block.theref.  with K -spar. diurets./K -supplem./K -contain.salt substit./ other   ther.& switch.to diff. meds.should woman become pregn., consid.
                                                     +
                                               +
       not recomm., incr. mortalit.report.in HF pts.on concom.ACE inhibit./   drugs incr. K -lev.  alter. meds.if pregn.contempl., monit.electrol.bal.in pts. on diuret.,
                                          +
       beta-block., hepat. impairm.hist., monit.bld.urea & serum creatinine   decr.Ca excret.lead.to poss.elev.ser. Ca levels, discont.ther.bef.start.
       in pts.with bilat.& unilat.ren. artery stenos., monit.ser.K in elderly/ren.  MYLACAND PLUS, Mylan  parathyroid funct. tests, poss.incr.in cholesterol & triglyceride levels.
                             -
       impairm. & concom.K-spar.diuret., bil.-obstruct.disords.  Candesartan cilexetil 16 mg, hydrochlorothiazide 12,5 mg  Drug interactions: Potent.of other antihypertens., addit.hyper-
                -
       Drug interactions: Antihypertens.eff.antagon by NSAID’s, sym-  Indications: Essent.hypertens. in pts.stabilis.on same dos.of in-  kalaem.eff.with K supplem./K-spar.& thiazide diuret.& other meds.
       pathomimet.reduc. antihypertens. eff., incr.ser.K  lev with K spar.  div.compon.  caus.hyperkalaem., rifampic.& fluconaz.reduc.act.metabol., NSAID’s
                                 -
                           +
           -
                 -
       diuret./K supplem. or Ksalt substit.  (S3) TABS, 45/7.1.3/0394  may reduce diuret./natriuret./antihypertens.eff., alcoh./barbit./narcot.
                                     719506-001: 16/12,5 mg, 30, R155,52
       MIZART, Mylan [P/S]           Dosage: Recomm.dos: 1 tab.dly. Antihypertens. eff. gen.attain.  potent.orthostat.hypotens., intensif.electrol.deplet.with corticoster.&
                                                                  ACTH, decr.respons.to press.amines., incr.responsiven.to nondepola-
       Telmisartan                   within 4 wks.                ris.skelet.musc.relax., reduc.clear.of Li, absorpt.of hydrochlorothiazide
       Indications: Mild to mod.hypertens.alone/ combin. with hydro-  Contra-indications: Hypersens.to sulfonam. deriv meds., angi-  imp.in pres.of anionic exchange resins.
       chlorothiazide.               oed.hist.relat.to prev.ACE inhib./angiotens.recept.blocks., heredit./
       (S3) TABS, 45/7.1.3/0606, 0607  idiopath. angioed., hypertroph.obstruct.cardiomyopathy, mod.to sev.  NORMOTEN, (Activo) Trinity [P/S]
       720439-001: 40 mg, 30, R147,73  imp.ren.funct., bil.ren.art.stenos., stenos.in pres.of sngl. kidn., aort.  Losartan potassium
       720440-001: 80 mg, 30, R147,73  stenos., concom.K  spar.diurets., porphyr., Li-ther., safety in pregn.&   Indications: Hypertens
                                            +</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page149.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>&nbsp;&nbsp;&nbsp;<a href="page146.html">146</a>&nbsp;&nbsp;&nbsp;<a href="page147.html">147</a>&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>&nbsp;&nbsp;&nbsp;<a href="page152.html">152</a>&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>
             </td>
             <td width="35%"><a href="page151.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page151.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
